A Phase 3 interventional study of rectal misoprostol 600mg in Post Partum Hemorrhage, sponsored by sarah mohamed hassan. Status unknown at 1 site in Egypt. Open to female participants aged 20 Years to 35 Years. Per ClinicalTrials.gov, last updated 2018-03-13.
Sponsored by sarah mohamed hassan · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies testing misoprostol in Postpartum Hemorrhage — 2 open to participants now, 2 under way, 1 of them phase 3. Misoprostol · Postpartum Hemorrhage.
Among the 59 studies testing misoprostol in Postpartum Hemorrhage, this one is the 44th largest by planned enrollment, is one of 9 that started in 2018, is one of 10 in phase 3, and was the 38th registered.
469 studies on the registry are indexed under Postpartum Hemorrhage; 76 are open to participants now.
Browse Postpartum Hemorrhage studies →2 of the 59 studies testing misoprostol in Postpartum Hemorrhage are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 20–40 · Women only · Healthy volunteers
Assiut University
Ages 18+
By country, each count listing its studies:
Misoprostol: first FDA approval 1988 (CYTOTEC). What it is approved for, and how studies give it, is on its page →
Of the 42 Postpartum Hemorrhage studies recruiting now, 21 (50%) set no upper age limit and 21 (50%) stop at 75 or younger; 6 take children under 18; 21 take healthy volunteers.
This study: 20 Years to 35 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 11 · Phase 3 13 · Phase 4 13
First in 1999; this study’s year is marked. 9 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 140 is close to the median of 148 across 360 interventional studies indexed under Postpartum Hemorrhage.
Median enrollment 240 across the 59 interventional studies. Of the 43 that completed or were terminated, 4 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 59 has an industry lead sponsor. The 10 most frequent:
sarah mohamed hassan is the lead sponsor of 4 studies on the registry; none are open to participants now.
sarah mohamed hassan has 1 study filed under Postpartum Hemorrhage — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 59 studies testing misoprostol in Postpartum Hemorrhage, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
comparison of the effect of misoprostol before and after cesarean on the blood loss
70 women who received 600 mg misoprostol rectally preoperatively versus 70 women who received 600 mg misoprostol postoperatively at operating theatre
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
70 women who received 600 mg misoprostol rectally preoperatively before cesarean section
Drug: rectal misoprostol 600mg
70 women who received 600 mg misoprostol postoperatively at operating theatre after cesarean section
Drug: rectal misoprostol 600mg
70 women who received 600 mg misoprostol postoperatively at operating theatre
intraoperative blood loss
Difference in weight of linen towels (gm)+Volume of contents of suction bottle (ml)
Time frame: the operation time
postoperative blood loss
weighing the soaked napkins after collection of soaked towel
Time frame: every 6 hours during first 24 hours.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Mar 2018; primary completion for Sep 2018, 6 months later.
Of 20 phase 3 interventional studies under Postpartum Hemorrhage, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 38. This study's planned 6 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Misoprostol
sarah mohamed hassan